Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.

Osborne, C K; Pippen, J; Jones, S E; Parker, L M; Ellis, M; Come, S; Gertler, S Z; May, J T; Burton, G; Dimery, I; Webster, A; Morris, C; Elledge, R; Buzdar, A

Osborne, C K; Pippen, J; Jones, S E; Parker, L M; Ellis, M; Come, S; Gertler, S Z; May, J T; Burton, G; Dimery, I; Webster, A; Morris, C; Elledge, R; Buzdar, A.

Affiliation

Osborne CK; Breast Center at Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA. kosborne@breastcenter.tmc.edu

J Clin Oncol ; 20(16): 3386-95, 2002 Aug 15.

Article in En | MEDLINE | ID: mdl-12177098

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Breast Neoplasms / Antineoplastic Agents, Hormonal / Estradiol / Estrogen Antagonists / Nitriles Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: J Clin Oncol Year: 2002 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links